8-K: Tivic Health Terminates Fulfillment Agreement to Cut Costs, Transitions to New Logistics

Tivic Health Systems terminated its fulfillment services agreement with ALOM Technologies to reduce costs and transitioned to new logistics and in-house assembly.

Summary

• Tivic Health Systems terminated its fulfillment services agreement with ALOM Technologies on August 1, 2024.
• The agreement, which began on November 25, 2022, and was amended on March 5, 2024, covered assembly, procurement, storage, returns, and fulfillment services.
• Tivic Health terminated the agreement for convenience to reduce direct and indirect costs related to product manufacturing and distribution.
• The company did not incur any material early termination penalties.
• Tivic Health has transitioned to third-party logistics and storage services from alternate suppliers without material minimums.
• The company has also established in-house assembly and testing capabilities.
• The transition was completed without service disruptions, and current capacity is expected to meet future demand.
• Prior to termination, ALOM's services were based on fixed hourly rates and unit pricing, with a $25,000 minimum monthly purchase requirement starting April 1, 2023, which was waived from January 2024 through June 2024.
• The initial term of the agreement was set to end on December 31, 2024, with automatic annual renewals.

Sentiment

Score: 7

Explanation: The document indicates a positive strategic move to reduce costs and improve operational efficiency, but also includes standard risk disclosures.

Positives

• The termination of the ALOM agreement is expected to reduce both direct and indirect costs for Tivic Health.
• The company has successfully transitioned to new logistics providers without service disruptions.
• Establishing in-house assembly and testing capabilities provides greater control over the manufacturing process.
• The new logistics agreements do not have material minimum purchase requirements, offering more flexibility.
• The company did not incur any penalties for terminating the agreement.

Risks

• The document contains forward-looking statements that involve risks and uncertainties.
• Actual results may differ from those expressed in forward-looking statements due to various factors.

Future Outlook

Tivic Health foresees that its current capacity will be sufficient to meet demand for the foreseeable future.

Management Comments

• The company terminated the agreement for convenience, in furtherance of its efforts to continue to reduce both direct and indirect costs associated with product manufacturing and distribution.
• The company completed the transition with no disruptions to service and foresees current capacity will be sufficient to meet demand for the foreseeable future.

Industry Context

This move reflects a trend among companies to optimize their supply chains and reduce costs by bringing some operations in-house and seeking more flexible logistics solutions.

Comparison to Industry Standards

• Many companies in the medical device and consumer health sectors are exploring ways to reduce supply chain costs and improve efficiency.
• Establishing in-house assembly and testing capabilities is a common strategy for companies seeking greater control over product quality and manufacturing timelines.
• The move to third-party logistics without minimum purchase requirements is similar to strategies employed by other companies to reduce fixed costs and improve flexibility.

Stakeholder Impact

• Shareholders may view the cost-cutting measures positively.
• Employees may be impacted by the shift to in-house assembly and testing.
• Customers should not experience any service disruptions due to the transition.
• Suppliers may be impacted by the change in logistics providers.

Key Dates

Keywords

fulfillment services, logistics, cost reduction, supply chain, manufacturing, assembly, Tivic Health, ALOM Technologies